Pharma Microbiology Testing Kits Market Report 2026

Pharma Microbiology Testing Kits Market Overview

• Pharma Microbiology Testing Kits market size has reached to $7.26 billion in 2025 • Expected to grow to $11.98 billion in 2030 at a compound annual growth rate (CAGR) of 10.8% • Growth Driver: Growing Prevalence Of Infectious Diseases Fueling The Growth Of The Market Due To Increasing Demand For Accurate And Rapid Pathogen Detection • Market Trend: AI Integration In Pharma Microbiology Testing • North America was the largest region in 2025 and Western Europe is the fastest growing region.

What Is Covered Under Pharma Microbiology Testing Kits Market?

The pharma microbiology testing kits detect contamination and uphold good standards. They are used to detect the microbial limits among drugs, vaccines, and other biologics. The main products of pharma microbiology testing kits are consumables and equipment. The pharma microbiology testing kits consumables are products used to detect the microbial limits among drugs, vaccines, and other biologics. The various tests performed by pharma microbiology testing kits are endotoxin testing, sterility testing, microbial examination, environmental monitoring, and others that are used by end-users such as hospitals and diagnostic centers, custom lab service providers, and academic and research institutes.

What Is The Pharma Microbiology Testing Kits Market Growth Forecast?

The pharma microbiology testing kits market size is expected to see rapid growth in the next few years. It will grow to $11.98 billion in 2030 at a compound annual growth rate (CAGR) of 10.8%. The growth in the forecast period can be attributed to biopharmaceutical pipeline growth, rapid testing technology adoption, regulatory stringency increase, contract manufacturing expansion, automation in quality control. Major trends in the forecast period include increased sterility testing frequency, rising adoption of rapid microbial detection, expansion of environmental monitoring programs, higher demand for ready-to-use test kits, outsourcing of microbiology testing services.

Global Pharma Microbiology Testing Kits Market Segmentation

1) By Product: Consumables, Equipment 2) By Test: Endotoxin Testing, Sterility Testing, Microbial Examination, Environmental Monitoring, Other Tests 3) By End User: Hospitals And Diagnostic Centers, Custom Lab Service Providers, Academic And Research Institutes Subsegments: 1) By Consumables: Media and Reagents, Test Kits, Sample Collection Containers 2) By Equipment: Incubators, Autoclaves, Microbial Identification Systems

What Is The Driver Of The Pharma Microbiology Testing Kits Market?

The growing prevalence of infectious diseases is expected to propel the growth of the pharma microbiology testing kits market going forward. Infectious diseases are illnesses caused by pathogenic microorganisms, such as bacteria, viruses, fungi, or parasites, that can be transmitted directly or indirectly from one individual to another. The rate of infectious disease incidence is rising due to increased travel, which facilitates the rapid spread of pathogens across borders. Pharma microbiology testing kits aid in infectious disease diagnosis by providing accurate and rapid detection of pathogens, making them essential for timely clinical decision-making. They improve laboratory efficiency by enabling reliable testing and supporting effective treatment and outbreak management. For instance, in February 2024, according to the UK Health Security Agency, a UK-based government agency, tuberculosis (a contagious bacterial infection that primarily affects the lungs) cases in England rose to 4,850 in 2023, an increase of 10.7% from 4,380 cases in 2022. Therefore, the growing prevalence of infectious diseases is driving the growth of the pharma microbiology testing kits industry.

Key Players In The Global Pharma Microbiology Testing Kits Market

Major companies operating in the pharma microbiology testing kits market are F. Hoffmann-La Roche AG, Becton Dickinson and Company, Abbott Laboratories, ThermoFisher Scientific, SGS SA, Toxikon Corp., Pace Analytical Services, Boston Analytics, Charles River Laboratories International, Nelson Laboratories, Siemens healthcare AG, Hologic Inc., Neogen Corporation, Shimadzu Corporation, Merck KGaA, Agilent TechnologiesInc., QIAGEN N.V., Bruker Corporation, bioMérieux SA, Lucideon, Lonza Group AG, MilliporeSigma, Hardy Diagnostics, Sartorius AG, 3M Company, Waters Corporation, PerkinElmer Inc., Luminex Corporation

Global Pharma Microbiology Testing Kits Market Trends and Insights

Major companies operating in the pharma microbiology testing kits market are focusing on the use of innovative technologies, such as artificial intelligence-powered software, to boost efficiency, enhance diagnostic accuracy, and streamline laboratory workflows. Artificial intelligence-powered software in this context refers to sophisticated algorithms that analyze complex data from diagnostic instruments to aid in the detection and identification of pathogens. For instance, in May 2023, Becton, Dickinson, and Company, a US-based medical device company, received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its new BD Kiestra MRSA Imaging Application, which utilizes artificial intelligence (AI) to enhance the diagnosis of Methicillin-resistant Staphylococcus aureus (MRSA). The application automates the inspection of Petri dishes, traditionally a labor-intensive and time-consuming task. It analyzes bacterial growth on BBL CHROMagar MRSA II plates and can quickly identify specimens that show no significant growth, allowing for faster processing and release of negative results.

What Are Latest Mergers And Acquisitions In The Pharma Microbiology Testing Kits Market?

In September 2024, Eurofins Scientific Inc., a Luxembourg-based biopharma product testing company, acquired Infinity Laboratories Inc. for an undisclosed amount. With this acquisition, Eurofins aims to expand its microbiology testing capabilities for the pharmaceutical sector, strengthen its presence in North America, and enhance its portfolio of high-quality analytical and regulatory testing services for drug development and manufacturing. Infinity Laboratories is a US-based pharmaceutical microbiology testing company that provides bioburden, sterility, endotoxin, and other microbiological assays for drug development and quality control.

Regional Outlook

North America was the largest region in the pharma microbiology testing kits market in 2025. Western Europe was the second-largest region in the global pharma microbiology testing kits market report. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Pharma Microbiology Testing Kits Market?

The pharma microbiology testing kits market consists of sales of rapid test systems, common rapid test kits, rapid tests for salmonella, PCR test, and lateral flow. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.